These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 29584591)

  • 1. Genetic variants of vascular endothelial growth factor predict risk and survival of gliomas.
    Linhares P; Viana-Pereira M; Ferreira M; Amorim J; Nabiço R; Pinto F; Costa S; Vaz R; Reis RM
    Tumour Biol; 2018 Mar; 40(3):1010428318766273. PubMed ID: 29584591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic Variants of VEGF (rs201963 and rs3025039) and KDR (rs7667298, rs2305948, and rs1870377) Are Associated with Glioma Risk in a Han Chinese Population: a Case-Control Study.
    Zhang J; Yang J; Chen Y; Mao Q; Li S; Xiong W; Lin Y; Chen J; Ge J
    Mol Neurobiol; 2016 May; 53(4):2610-8. PubMed ID: 26093379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of TGF-β1 -509C/T and 869T/C polymorphisms on glioma risk and patient prognosis.
    Vieira de Castro J; Gonçalves CS; Costa S; Linhares P; Vaz R; Nabiço R; Amorim J; Viana-Pereira M; Reis RM; Costa BM
    Tumour Biol; 2015 Aug; 36(8):6525-32. PubMed ID: 25813152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EphA2, vascular endothelial growth factor, and vascular endothelial growth factor correlate with adverse outcomes and poor survival in patients with glioma.
    Shen L; Sun R; Kan S; Wang Z; Yu Z
    Medicine (Baltimore); 2021 Jan; 100(3):e23985. PubMed ID: 33545987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of EGFR genetic variants on glioma risk and patient outcome.
    Costa BM; Viana-Pereira M; Fernandes R; Costa S; Linhares P; Vaz R; Pinheiro C; Lima J; Soares P; Silva A; Pardal F; Amorim J; Nabiço R; Almeida R; Alegria C; Pires MM; Pinheiro C; Carvalho E; Oliveira P; Lopes JM; Reis RM
    Cancer Epidemiol Biomarkers Prev; 2011 Dec; 20(12):2610-7. PubMed ID: 21960689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of ANXA5 polymorphisms on glioma risk and patient prognosis.
    Guo X; Song J; Zhao J; Wang B; Yang Z; Sun P; Hu M
    J Neurooncol; 2019 Mar; 142(1):11-26. PubMed ID: 30536196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Possible association between polymorphisms of human vascular endothelial growth factor A gene and susceptibility to glioma in a Chinese population.
    Li R; Zhao Y; Fan W; Chen H; Chen Y; Liu Y; Chen G; Zhou K; Huang F; Mao Y; Zhou L; Lu D; Shugart YY
    Int J Cancer; 2011 Jan; 128(1):166-75. PubMed ID: 20209496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 gene polymorphisms in patients with gastrointestinal stromal tumors.
    Kang BW; Kim JG; Chae YS; Bae HI; Kwon O; Chung HY; Yu W; Song HS; Kang YN; Ryu SW; Lee KH; Bae YK; Choi JH; Kim SW; Ryoo HM; Cho CH; Chae HD; Park KW; Gu MJ; Bae BJ
    Asia Pac J Clin Oncol; 2014 Jun; 10(2):e40-5. PubMed ID: 23551429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular endothelial growth factor (VEGF) gene polymorphisms (rs699947, rs833061, and rs2010963) and psoriatic risk in South Indian Tamils.
    Sudhesan A; Rajappa M; Chandrashekar L; Ananthanarayanan PH; Thappa DM; Satheesh S; Chandrasekaran A
    Hum Immunol; 2017 Oct; 78(10):657-663. PubMed ID: 28803785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastric cancer risk predisposition and prognostic significance of vascular endothelial growth factor (VEGF) gene polymorphisms--a case-control study in an Omani population.
    Al-Moundhri MS; Al-Nabhani M; Burney IA; Al-Farsi AA; Al-Bahrani B
    Mol Carcinog; 2009 Dec; 48(12):1170-6. PubMed ID: 19676106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three single nucleotide polymorphisms of the vascular endothelial growth factor (VEGF) gene and glioma risk in a Chinese population.
    Jiang H; Lian M; Xie J; Li J; Wang M
    J Int Med Res; 2013 Oct; 41(5):1484-94. PubMed ID: 24008569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Replication of GWAS identifies RTEL1, CDKN2A/B, and PHLDB1 SNPs as risk factors in Portuguese gliomas patients.
    Viana-Pereira M; Moreno DA; Linhares P; Amorim J; Nabiço R; Costa S; Vaz R; Reis RM
    Mol Biol Rep; 2020 Feb; 47(2):877-886. PubMed ID: 31721021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Germline Polymorphisms of the VEGF Pathway Predict Recurrence in Nonadvanced Differentiated Thyroid Cancer.
    Marotta V; Sciammarella C; Capasso M; Testori A; Pivonello C; Chiofalo MG; Gambardella C; Grasso M; Antonino A; Annunziata A; Macchia PE; Pivonello R; Santini L; Botti G; Losito S; Pezzullo L; Colao A; Faggiano A
    J Clin Endocrinol Metab; 2017 Feb; 102(2):661-671. PubMed ID: 27849428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery and validation of vascular endothelial growth factor (VEGF) pathway polymorphisms in esophageal adenocarcinoma outcome.
    Eng L; Azad AK; Qiu X; Kong QQ; Cheng D; Ying N; Tse A; Kuang Q; Dodbiba L; Renouf DJ; Marsh S; Savas S; Mackay HJ; Knox JJ; Darling GE; Wong RK; Xu W; Liu G; Faluyi OO
    Carcinogenesis; 2015 Sep; 36(9):956-62. PubMed ID: 26014353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular endothelial growth factor gene polymorphisms and colorectal cancer risk: a meta-analysis.
    Zhou LP; Luan H; Dong XH; Jin GJ; Man DL; Shang H
    Genet Mol Res; 2011 Oct; 10(4):3674-88. PubMed ID: 22058001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An exploratory association of polymorphisms in angiogenesis-related genes with susceptibility, clinical response and toxicity in gastrointestinal stromal tumors receiving sunitinib after imatinib failure.
    Ravegnini G; Nannini M; Zenesini C; Simeon V; Sammarini G; Urbini M; Gatto L; Saponara M; Biasco G; Pantaleo MA; Venturoli N; Hrelia P; Angelini S
    Angiogenesis; 2017 Feb; 20(1):139-148. PubMed ID: 27896475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variants in angiogenesis-related genes and the risk of clear cell renal cell carcinoma.
    Qin C; Chen J; Li J; Ju X; Zhang S; Cao Q; Han Z; Li P; Shao P; Wang M; Zhang Z; Gu M; Zhang W; Yin C
    Mutagenesis; 2014 Nov; 29(6):419-25. PubMed ID: 25239121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Common single nucleotide polymorphisms in the vascular endothelial growth factor gene and colorectal cancer risk.
    Hofmann G; Langsenlehner U; Renner W; Langsenlehner T; Yazdani-Biuki B; Clar H; Gerger A; Wehrschuetz M; Samonigg H; Krippl P
    J Cancer Res Clin Oncol; 2008 May; 134(5):591-5. PubMed ID: 17938959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relation of vascular endothelial growth factor (VEGF) gene polymorphisms on VEGF levels and the risk of vasoocclusive crisis in sickle cell disease.
    Al-Habboubi HH; Mahdi N; Abu-Hijleh TM; Abu-Hijleh FM; Sater MS; Almawi WY
    Eur J Haematol; 2012 Nov; 89(5):403-9. PubMed ID: 22925497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic polymorphisms in the vascular endothelial growth factor gene and breast cancer risk. The Austrian "tumor of breast tissue: incidence, genetics, and environmental risk factors" study.
    Langsenlehner U; Wolf G; Langsenlehner T; Gerger A; Hofmann G; Clar H; Wascher TC; Paulweber B; Samonigg H; Krippl P; Renner W
    Breast Cancer Res Treat; 2008 May; 109(2):297-304. PubMed ID: 17636397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.